Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

RARE PHOTOS: Cardiff oncology | Vintage Vibes

Why Is Cardiff Oncology Stock Trading Lower After Colorectal Cancer Data?

As advancements in cancer treatment continue to evolve, the pursuit of more effective therapies for metastatic colorectal cancer remains a critical focus in the pharmaceutical industry. Cardiff Oncology, Inc. (NASDAQ:CRDF) on Tuesday released data from the ongoing CRDF-004 Phase 2 clinical trial evaluating onvansertib in combination with standard-of-care (SoC) in…

Benzinga · Jul 30, 2025

Cardiff Oncology Shares Slide Over 26% In Premarket Trading After Mixed Q2

Following a disappointing second-quarter earnings report, Cardiff Oncology Inc. (NASDAQ:CRDF) experienced a 26.28% drop in its stock value during pre-market trading on Wednesday after reporting mixed Q2 earnings.

Benzinga · Jul 30, 2025

Hoth Therapeutics And 3 Other Stocks Under $3 Insiders Are Aggressively Buying

The Dow Jones jumped by around 197 points on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment…

Benzinga · Sep 20, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

12 Health Care Stocks Moving In Monday's Intraday Session

Benzinga · Sep 19, 2022

12 Health Care Stocks Moving In Monday's Intraday Session

Benzinga · Jul 18, 2022

12 Health Care Stocks Moving In Friday's Intraday Session

Benzinga · Jun 10, 2022

12 Health Care Stocks Moving In Thursday's Intraday Session

Benzinga · Jun 9, 2022

Read news from The Economist, FT, and more,
with one subscription

Cardiff Oncology: Q4 Earnings Insights

Cardiff Oncology (NASDAQ:CRDF) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:10 PM. Here's what investors need to know about the announcement.

Benzinga · Feb 25, 2022

Why Cardiff Oncology Shares Are Falling

Cardiff Oncology Inc (NASDAQ: CRDF) shares are trading lower after the company announced data from its lead clinical program evaluating onvansertib in combination with standard-of-care FOLFIRI/bevacizumab.

Benzinga · Jan 19, 2022

Coverage From

Benzinga

Organisations

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.